Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia

BACKGROUND: In July 2007, amid some controversy over cost, Zambia was the first African country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a wide scale. METHODS: We compared drug substitutions, mortality, and “programmatic failure” among adults starting...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chi, Benjamin H., Mwango, Albert, Giganti, Mark, Mulenga, Lloyd B., Tambatamba-Chapula, Bushimbwa, Reid, Stewart E., Bolton-Moore, Carolyn, Chintu, Namwinga, Mulenga, Priscilla L., Stringer, Elizabeth M., Sheneberger, Robert, Mwaba, Peter, Stringer, Jeffrey S. A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2862003/
https://ncbi.nlm.nih.gov/pubmed/20009765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3181c6c65c
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia